Results 271 to 280 of about 861,404 (347)

Evaluating the effects of a hospital utilisation improvement program on platelet transfusions: A pre‐post study

Transfusion Medicine, EarlyView.
Abstract Background Annually millions of platelet concentrate (PC) are transfused worldwide. The decision regarding PC transfusion is often complex; therefore, the implementation of a hospital programme designed to streamline and facilitate the decision‐making process is beneficial. Such a programme helps standardise transfusion practices, ensures that
Piotr F. Czempik, Jakub Rudzki, Michał Porada   +2 more
wiley   +1 more source

Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors. [PDF]

World J Surg Oncol
Hu H, Lei D, Liang Y.
europepmc   +1 more source

Comparative evaluation of blood component preparation with the top‐and‐top and top‐and‐bottom methods: A change in Uruguay

Transfusion Medicine, EarlyView.
Abstract Background Hospital de Clínicas, in conjunction with the Universidad de la República UDELAR in Uruguay, evaluated the quality of blood components after separation with a top‐and‐bottom (TB) system, comparing it with the top‐and‐top (TT) system and verifying compliance with local and international standards. Study Design and Methods Whole blood
Natalia Méndez Acosta, Gabriela Rivas Alén, Ismael Rodriguez Grecco, Allexandra Díaz, Dalia Moreno, Ludwig R. Frontier Ramos   +5 more
wiley   +1 more source

Successful Hemostasis With Platelet Transfusion and Tranexamic Acid, and Inhibitor Elimination With Cyclosporine, in Steroid-Resistant Acquired Coagulation Factor V Deficiency Caused by Antibiotic Readministration. [PDF]

Case Rep Hematol
Togitani K, Yamamoto M, Tanaka S, Aono R, Uemura Y.   +4 more
europepmc   +1 more source

Hepatitis E virus screening in Irish blood donors: Seven years of individual donation nucleic acid testing reveals a frequent blood donor infection—but what is the risk?

Transfusion Medicine, EarlyView.
Abstract Background Screening blood donations for HEV RNA mitigates the risk of transfusion‐transmitted HEV infection (TT‐HEV), a recognised blood safety issue in Europe. This study reports the findings of government‐funded HEV RNA blood donation screening 2016–2022 and includes an estimate of residual risk. Method Donation samples were universally and
Niamh O'Flaherty, Marice Mullarkey, Lisa Burke, Pádraig Williams, Jonathan Dean, Jola Szulc, Allison Waters   +6 more
wiley   +1 more source

Avatrombopag for the salvage treatment of platelet transfusion refractoriness. [PDF]

Ther Adv Hematol
Qin Y, Wang Y, Zhang Y, Jiao Y, Ye J.
europepmc   +1 more source

Romiplostim Reduces Platelet Transfusion Needs in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation. [PDF]

Cureus
Surya Prakash V, Nair RR, Soneji D, Thareja S, Rao PP, Debnath J, Chowdhary GS, Guleria B, Kushwaha N, Biswas A, H R, Bohra V, Khurana H, Sharma S, Mishra K.   +14 more
europepmc   +1 more source

Platelet transfusion.

Haematologica, 2003
Elena, Coluccio, Paolo, Rebulla
openaire   +1 more source

Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients. [PDF]

Blood Adv
Boothby AB, Tanner MK, Alswied A, Youngs D, Bribiesca Rodriguez J, Bikkani T, Cha N, Gernsheimer T, Gimferrer I, Hess JR, Sokol-Hessner L, Marivada S, Nash MG, Flegel WA, Vassallo RR, Stroncek DF, Tsang HC, Panch SR.   +17 more
europepmc   +1 more source

Utility of thromboelastography with platelet mapping for monitoring platelet transfusion in qualitative platelet disorders. [PDF]

J Thromb Haemost
Lee RH, Rudran T, Bergmeier W.
europepmc   +1 more source